MetaADEDB 2.0 @ LMMD
Tazocilline
(LITBAYYWXZOHAW-QNWQYGOSSA-N)
Structure
SMILES
OC(=O)[C@@H]1N2C(=O)C[C@H]2S(=O)(=O)[C@@]1(C)Cn1ccnn1.CCN1CCN(C(=O)C1=O)C(=O)NC(C(=O)N[C@@H]1C(=O)N2[C@@H]1SC([C@@H]2C(=O)O)(C)C)c1ccccc1
Molecular Formula:
C33H39N9O12S2
Molecular Weight:
817.846
Log P:
-0.1493
Hydrogen Bond Acceptor:
22
Hydrogen Bond Donor:
4
TPSA:
312.57
CAS Number(s):
123683-33-0
Synonym(s)
1.
Tazocilline
External Link(s)
PubChem Compound44320150
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NeutropeniaFAERS: 5US FAERS
2Accidental overdoseFAERS: 4US FAERS
3HypersensitivityFAERS: 4US FAERS
4Respiratory distressFAERS: 4US FAERS
5ThrombocytopeniaFAERS: 4US FAERS
6AgranulocytosisFAERS: 3US FAERS
7CholestasisFAERS: 3US FAERS
8EosinophiliaFAERS: 3US FAERS
9Febrile NeutropeniaFAERS: 3US FAERS
10MalaiseFAERS: 3US FAERS
11PainFAERS: 3US FAERS
12PruritusFAERS: 3US FAERS
13VomitingFAERS: 3US FAERS
14Abdominal PainFAERS: 2US FAERS
15Accidental exposureFAERS: 2US FAERS
16Anaphylactic shockFAERS: 2US FAERS
17BicytopeniaFAERS: 2US FAERS
18BradycardiaFAERS: 2US FAERS
19Burning sensationFAERS: 2US FAERS
20Chest discomfortFAERS: 2US FAERS
21ChillsFAERS: 2US FAERS
22ErythemaFAERS: 2US FAERS
23FatigueFAERS: 2US FAERS
24HypotensionFAERS: 2US FAERS
25Occupational exposure to productFAERS: 2US FAERS
26Respiratory arrestFAERS: 2US FAERS
27AgitationFAERS: 1US FAERS
28Alanine Aminotransferase IncreasedFAERS: 1US FAERS
29Altered state of consciousnessFAERS: 1US FAERS
30AmnesiaFAERS: 1US FAERS
31Application site drynessFAERS: 1US FAERS
32Application site papulesFAERS: 1US FAERS
33Application site pruritusFAERS: 1US FAERS
34ArthralgiaFAERS: 1US FAERS
35Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
36AstheniaFAERS: 1US FAERS
37Biliary tract infectionFAERS: 1US FAERS
38Blood creatine phosphokinase increasedFAERS: 1US FAERS
39Blood creatinine increasedFAERS: 1US FAERS
40Blood lactate dehydrogenase increasedFAERS: 1US FAERS
41Bone painFAERS: 1US FAERS
42Cardiac ArrestFAERS: 1US FAERS
43Cell DeathFAERS: 1US FAERS
44CholangitisFAERS: 1US FAERS
45Clostridium difficile colitisFAERS: 1US FAERS
46Coagulation factor V level decreasedFAERS: 1US FAERS
47ColitisFAERS: 1US FAERS
48DehydrationFAERS: 1US FAERS
49DeliriumFAERS: 1US FAERS
50Diabetes MellitusFAERS: 1US FAERS
51Disseminated Intravascular CoagulationFAERS: 1US FAERS
52Drug level above therapeuticFAERS: 1US FAERS
53Drug prescribing errorFAERS: 1US FAERS
54EpistaxisFAERS: 1US FAERS
55Febrile bone marrow aplasiaFAERS: 1US FAERS
56Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
57HeadacheFAERS: 1US FAERS
58Inappropriate schedule of drug administrationFAERS: 1US FAERS
59Incorrect dose administeredFAERS: 1US FAERS
60LeukopeniaFAERS: 1US FAERS
61Lymphocyte count increasedFAERS: 1US FAERS
62MenorrhagiaFAERS: 1US FAERS
63MydriasisFAERS: 1US FAERS
64NauseaFAERS: 1US FAERS
65Platelet aggregation abnormalFAERS: 1US FAERS
66Prescribed overdoseFAERS: 1US FAERS
67Product preparation errorFAERS: 1US FAERS
68Prostatic AdenomaFAERS: 1US FAERS
69Prothrombin time ratio decreasedFAERS: 1US FAERS
70Renal tubular disorderFAERS: 1US FAERS
71Sense of oppressionFAERS: 1US FAERS
72Similar reaction on previous exposure to drugFAERS: 1US FAERS
73TachycardiaFAERS: 1US FAERS
74TonsillitisFAERS: 1US FAERS
75Urinary RetentionFAERS: 1US FAERS
76UrticariaFAERS: 1US FAERS
77Venous InjuryFAERS: 1US FAERS
78Weight decreasedFAERS: 1US FAERS
79WheezingFAERS: 1US FAERS
80Wrong technique in drug usage processFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.